Similarly, knocking out GCGR and treatment with GCGR antagonist (LY2409021) induced liver fat accumulation in zebrafish and patients with type 2 diabetes (T2D), respectively (Guzman et al., 2017; Kang et al., 2020). The gene discussed is GCGR; the disease is type 2 diabetes mellitus.